<DOC>
	<DOCNO>NCT02161692</DOCNO>
	<brief_summary>The purpose study determine whether use sequential high dose chemotherapy effective conventional dose ( i.e . 4 cycle cisplatin , etoposide , bleomycin [ PEB ] ) patient metastatic poor prognosis germ cell tumor .</brief_summary>
	<brief_title>Conventional Dose Versus High Dose Sequential Chemotherapy Poor Prognosis Germ Cell Tumors</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms , Germ Cell Embryonal</mesh_term>
	<mesh_term>Testicular Neoplasms</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Bleomycin</mesh_term>
	<criteria>Clinical Histological diagnosis germ cell tumor Metastatic disease Poor prognostic category accord International Germ Cell Collaborative Group ( IGCCCG ) classification No prior chemotherapy metastatic disease Unwillingness accomplish study procedures Any exist comorbidity could limit administration high dose chemotherapy Any psychiatric disorder could impact study compliance</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>